Harrow, Inc. Interest Expense, Other
Harrow, Inc. (HROW) reported Interest Expense, Other of $1.56 thousand for the 3-month period ending 2014-06-30, per its 10-Q filed 2014-08-13.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpenseOther · last filed 2014-08-13
- Harrow, Inc. interest expense, other for the quarter ending 2014-06-30 was $1.56K.
- Harrow, Inc. interest expense, other for the quarter ending 2012-12-31 was $0.00.
- Harrow, Inc. interest expense, other for fiscal 2012 was $24.66K.
| Period end | Interest Expense, Other 3 month | Interest Expense, Other 6 month | Interest Expense, Other 9 month | Interest Expense, Other 12 month | Interest Expense, Other 182 month | Interest Expense, Other 185 month | Interest Expense, Other 188 month |
|---|---|---|---|---|---|---|---|
| 2014-06-30 | $1.56K 10-Q · filed 2014-08-13 | $1.56K 10-Q · filed 2014-08-13 | |||||
| 2014-03-31 | $1.73M 10-Q · filed 2014-05-15 | ||||||
| 2013-12-31 | $1.73M 10-K · filed 2014-03-28 | ||||||
| 2013-09-30 | $1.73M 10-Q · filed 2013-11-06 | ||||||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | $24.66K 10-K · filed 2014-03-28 | |||||
| 2012-09-30 | $24.66K 10-Q · filed 2013-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |